Precipio (NASDAQ:PRPO) Posts Earnings Results

Precipio (NASDAQ:PRPO) posted its quarterly earnings data on Thursday. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, Zacks reports. Precipio had a negative net margin of 17.23% and a negative return on equity of 34.01%.

Precipio Price Performance

Shares of PRPO traded down $0.48 during trading hours on Thursday, reaching $6.18. 4,584 shares of the company’s stock traded hands, compared to its average volume of 7,956. The company has a current ratio of 0.73, a quick ratio of 0.60 and a debt-to-equity ratio of 0.02. The firm’s 50 day simple moving average is $7.12 and its 200-day simple moving average is $6.49. The stock has a market cap of $9.16 million, a PE ratio of -3.38 and a beta of 1.37. Precipio has a 12 month low of $4.31 and a 12 month high of $10.74.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.